KD-501, a standardized extract of Scrophularia buergeriana has both cognitive-enhancing and antioxidant activities in mice given scopolamine

Journal of Ethnopharmacology

Volumn 121, Issue 1, 2009, Pages 98-105

  Jeong, Eun Ju ^a   Ma, Choong Je ^b   Lee, Ki Yong ^a   Kim, Seung Hyun ^c   Sung, Sang Hyun ^a   Kim, Young Choong ^a  

^a Seoul National University   (South Korea)

^b Kangwon National University   (South Korea)

^c Elcomscience Co Ltd   (South Korea)

Author keywords

Acetylcholinesterase; Alzheimer's disease; Antioxidant activity; Cognitive enhancing activity; KD 501; Scrophularia buergeriana

Indexed keywords

ACETYLCHOLINESTERASE; CENTRAL STIMULANT AGENT; GLUTATHIONE; GLUTATHIONE REDUCTASE; KD 501; SCOPOLAMINE; SCROPHULARIA BUERGERIANA EXTRACT; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; AVOIDANCE BEHAVIOR; BRAIN CORTEX; COGNITION; CONTROLLED STUDY; DRUG DOSE COMPARISON; HIPPOCAMPUS; MALE; MAZE TEST; MOUSE; NONHUMAN; PLANT ROOT; SPATIAL MEMORY;

ACETYLCHOLINESTERASE; ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; AVOIDANCE LEARNING; CEREBRAL CORTEX; COGNITION; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HIPPOCAMPUS; MALE; MAZE LEARNING; MEMORY; MICE; MICE, INBRED ICR; NOOTROPIC AGENTS; PLANT EXTRACTS; PLANT ROOTS; SCROPHULARIA; SUPEROXIDE DISMUTASE;

MUS; SCROPHULARIA BUERGERIANA;

EID: 58049127052     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2008.10.006     Document Type: Article

References (49)

1. Amarowicz R., and Shahidi F. Antioxidant activity of peptide fractions of capelin protein hydrolysates. Food Chemistry 58 (1997) 355-359
2. Ballard C.G., Greig N.H., and Guillozet-Bongaarts A.L. Cholinesterases: roles in the brain during health and disease. Current Alzheimer Research 2 (2005) 307-318
3. Bartus R.T., Dean III R.L., Beer B., and Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science 217 (1982) 408-414
4. Beatty W.W., Butters N., and Janowsky D.S. Patterns of memory failure after scopolamine treatment: implications for cholinergic hypothesis of dementia. Behavioral and Neural Biology 45 (1986) 196-211
5. Bejar C., Wang R.H., and Weinstock M. Effect of rivastigmine on scopolamine-induced memory impairment in rats. European Journal of Pharmacology 383 (1999) 231-240
6. Blokland A. Acetylcholine: a neurotransmitter for learning and memory?. Brain Research 21 (1995) 285-300
7. Braida D., Paladini E., Griffini P., Lamerti M., Maggi A., and Sala M. An inverted U-shaped curve for heptylphysostigmine on radial maze performance in rats: comparison with other cholinesterase inhibitors. European Journal of Pharmacology 302 (1996) 13-20
8. Carlberg I., and Mannervik B. Purification and characterization of the flavoenzyme glutathione reductase from rat liver. The Journal of Biological Chemistry 25 (1975) 5475-5480
9. Carney J.M., Starke-Reed P.E., Oliver C.N., Landum R.W., Cheng M.S., and Wu J.F. Reversal of age-related increase in brain protein oxidation, decrease in enzyme activity and loss in temporal and spatial memory by chronic administration of the spin trapping compound N-tert-butyl-a-phenylnitrone. Proceedings of the National Academy of Sciences of the United States of America 88 (1991) 3633-3666
10. Chen L., Richardson J.S., Caldwell J.E., and Ang L.C. Regional brain activity of free radical defense enzyme in autopsy samples from patients with Alzheimer's disease and from nondemented controls. The International Journal of Neuroscience 75 (1994) 83-90
11. Cheng D.H., and Tang X.C. Comparative studies of huperzine A, E2020, and tacrine on behavior and cholinesterase activities. Pharmacology, Biochemistry, and Behavior 60 (1998) 377-386
12. Collerton D. Cholinergic function and intellectual decline in Alzheimer's disease. Neuroscience 19 (1986) 1-28
13. Dawson G.R., Bentley G., Drapper F., Rycroft W., Iversen S.D., and Pagella P.G. The behavioral effects of heptylphysostigmine, a new cholinesterase inhibitor, in tests of long-term and working memory in rodents. Pharmacology, Biochemistry, and Behavior 39 (1991) 865-871
14. Duck J.A., and Ayensu E.S. Medical Plants of China (1985), Algonac, MI p. 599
15. Ebert U., and Kirch W. Scopolamine model of dementia: electroencephalogram findings and cognitive performance. European Journal of Clinical Investigation 28 (1998) 944-949
16. El-Sherbiny D.A., Khalifa A.E., Attia A.S., and Eldenshary E.E.S. Hypericum perforatum extract demonstrates antioxidant properties against elevated rat brain oxidative status induced by amnestic dose of scopolamine. Pharmacology, Biochemistry, and Behavior 76 (2003) 523-533
17. Ellman G.L., Courtney K.D., Andre Jr. V., and Featherstone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochemical Pharmacology 7 (1961) 88-95
18. Flohe L., and Gunzler W.A. Assays of glutathione peroxidase. Methods in Enzymology 105 (1984) 114-121
19. Fodale V., Quattrone D., Trecroci C., Caminiti V., and Santamaria L.B. Alzheimer's disease and anaesthesia: implications for the central cholinergic system. British Journal of Anaesthesia 97 (2006) 445-452
20. Francis P.T., Palmer A.M., Snape M., and Wilcock G.K. The cholinergic hypothesis of Alzheimer's disease: a review of progress. Journal of Neurology, Neurosurgery, and Psychiatry 66 (1999) 137-147
21. Giovannini M.G., Casamenti F., Bartolini L., and Pepeu G. The brain cholinergic system as a target of cognition enhancers. Behavioural Brain Research 83 (1997) 1-5
22. Hattori M., Yamaji-T K., Kimagai H., Feng Y., and Takahashi K. Antioxidative activity of soluble elastine peptides. Journal of Agricultural and Food Chemistry 46 (1998) 2167-2170
23. JiansuNewMedical College (Ed.), 1997. Dictionary of Chinese Crude Drugs. Shanghai Scientific Technology Publisher, Shanghai, p. 769.
24. Jones R.W., Wesnes K.A., and Kirby J. Effects of NMDA modulation in scopolamine dementia. Annals of the New York Academy of Sciences 640 (1991) 241-244
25. Julkunen-Tiito R. Phenolic constituents in the leaves of northern willows, methods for the analysis of certain phenolics. Journal of Agricultural and Food Chemistry 33 (1985) 213-217
26. Kansci G., Genot C., Meynier A., and Gandemer G. The antioxidant activity of sine and its consequences on the volatile profiles of liposomes during iron/ascorbate induced phospholipids oxidation. Food Chemistry 60 (1997) 165-175
27. Katzman R. Alzheimer's disease. The New England Journal of Medicine 314 (1986) 964-973
28. Kim S.R., Hwang S.Y., Jang Y.P., Park M.J., Markelonis G.J., Oh T.H., and Kim Y.C. Protopine from Corydalis ternata has anticholinesterase and antiamnesic activities. Planta Medica 65 (1999) 218-221
29. Kim S.R., and Kim Y.C. Neuroprotective phenylpropanoid esters of rhamnose isolated from roots of Scrophularia buergeriana. Phytochemistry 54 (2000) 503-509
30. Kim S.R., Koo K.A., Sung S.H., Ma C.J., Yoon J.S., and Kim Y.C. Iridoids from Scrophularia buergeriana attenuate glutamate-induced neurotoxicity in rat cortical cultures. Journal of Neuroscience Research 74 (2003) 948-955
31. Kim S.R., Kang S.Y., Lee K.Y., Kim S.H., Markelonis G.J., Oh T.H., and Kim Y.C. Anti-amnestic activity of E-p-methoxycinnamic acid from Scrophularia buergeriana. Cognitive Brain Research 17 (2003) 454-461
32. Kim S.R., Sung S.H., Jang Y.P., Markelonis G.J., Oh T.H., and Kim Y.C. E-p-Methoxycinnamic acid protects cultured neuronal cells against neurotoxicity induced by glutamate. British Journal of Pharmacology 135 (2002) 1281-1291
33. Kopolman M.D., and Corn T.H. Cholinergic "blockage" as a model of cholinergic depletion. Brain 111 (1998) 1079-1110
34. Lee M.K., Choi O.G., Park J.H., Cho H.J., Ahn M.J., Kim S.H., Kim Y.C., and Sung S.H. Simultaneous determination of four active constituents in the roots of Schrophularia buergeriana by HPLC-DAD and LC-ESI-MS. Journal of Separation Science 30 (2007) 2345-2350
35. Lu S.C. Regulation of hepatic glutathione synthesis: current concepts and controversies. The FASEB Journal 13 (1999) 1169-1183
36. Marinova E.M., and Yanishlieva N.V. Antioxidative activity of extracts from selected species of the family Lamiaceae in sunflower oil. Food Chemistry 58 (1997) 245-248
37. Mattson M.P., and Pedersen W.A. Effects of amyloid precursor protein derivatives and oxidative stress on basal forebrain cholinergic systems in Alzheimer's disease. International Journal of Development Neuroscience 16 (1998) 626-642
38. McCord J.M., and Fridovich I. The utility of superoxide dismutase in studying free radical reactions. I. Radicals generated by interaction of sulfite, dimethyl sulfoxide, and oxygen. The Journal of Biological Chemistry 25 (1969) 6056-6063
39. Morris R.G. Development of a water maze procedure for studying spatial learning in the rat. Journal of Neuroscience Methods 11 (1984) 47-60
40. Muanza, D., Robert, R., Sparks, W., 1998. Antioxidant derived from lentil and its preparation and uses. U.S. Patent US5,762,936.
41. Ohno M., and Watanabe S. d-Cycloserine, a glycine site agonist, reverses working memory failure by hippocampal muscarinic receptor in rats. European Journal of Pharmacology 318 (1996) 267-271
42. Palmer A.M. The activity of the pentose phosphate pathway is increased in response to oxidative stress in Alzheimer's disease. Journal of Neural Transmission 106 (1999) 317-328
43. Pappolla M.A., Omar R.A., Kim K.S., and Robakis N.K. Immunohistochemical evidence of oxidative stress in Alzheimer's disease. The American Journal of Pathology 140 (1992) 621-628
44. Pong K. Oxidative stress in neurodegenerative disease: therapeutic implications for superoxide dismutase mimetics. Expert Opinion on Biological Therapy 3 (2003) 127-139
45. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., and Klenk D.C. Measurement of protein using bicinchoninic acid. Analytical Biochemistry 150 (1985) 76-85
46. Tietz F. Enzymatic method of quantitative determination of nanogram amounts of total and oxidized glutathione. Analytical Biochemistry 27 (1969) 502-522
47. Wesnes K.A., Simpson P.M., White L., Pinker S., Jertz G., Murphy M., and Siegfried K. Cholinesterase inhibition in the scopolamine model of dementia. Annals of the New York Academy of Science 640 (1991) 268-271
48. Wilson J.X. Antioxidant defense of the brain: a role for astrocytes. Canadian Journal of Physiology and Pharmacology 75 (1997) 1149-1163
49. Zemlan F.P., Thienhaus O.J., and Bosmann H.B. Superoxide dismutase activity in Alzheimer's disease: possible mechanism for paired helical filament formation. Brain Research 476 (1989) 160-162